This announcement is a separate document:
昭衍新药：关于现金收购美国Biomere公司100%股权交割完成的公告
Zhaoyan Pharmaceutical: Announcement on the completion of the cash purchase of 100% of the shares of Biomere in the US
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.